SYNJARDY 12.5/1000MG TABS 60’S

Synjardy is a prescription medication that combines two active ingredients: empagliflozin and metformin. It is primarily used to manage type 2 diabetes in adults. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine. Metformin, on the other hand, is a biguanide that improves insulin sensitivity, decreases hepatic glucose production, and enhances peripheral glucose uptake and utilization.

Synjardy is typically prescribed for patients who need additional glycemic control when diet and exercise alone are insufficient. It can also help with weight management and may reduce the risk of cardiovascular events in patients with type 2 diabetes. The combination of these two medications allows for a more effective approach to controlling blood sugar levels.